These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8626728)

  • 1. Stoichiometry of 2',5'-oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study.
    Cole JL; Carroll SS; Kuo LC
    J Biol Chem; 1996 Feb; 271(8):3979-81. PubMed ID: 8626728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RNase L by 2',5'-oligoadenylates. Biophysical characterization.
    Cole JL; Carroll SS; Blue ES; Viscount T; Kuo LC
    J Biol Chem; 1997 Aug; 272(31):19187-92. PubMed ID: 9235909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of RNase L by 2',5'-oligoadenylates. Kinetic characterization.
    Carroll SS; Cole JL; Viscount T; Geib J; Gehman J; Kuo LC
    J Biol Chem; 1997 Aug; 272(31):19193-8. PubMed ID: 9235910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
    Yoshimura A; Nakanishi M; Yatome C; Kitade Y
    J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.
    Naik S; Paranjape JM; Silverman RH
    Nucleic Acids Res; 1998 Mar; 26(6):1522-7. PubMed ID: 9490801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of oligoribonucleotides by the 2',5'-oligoadenylate- dependent ribonuclease L.
    Carroll SS; Chen E; Viscount T; Geib J; Sardana MK; Gehman J; Kuo LC
    J Biol Chem; 1996 Mar; 271(9):4988-92. PubMed ID: 8617774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.
    Rusch L; Dong B; Silverman RH
    Methods Enzymol; 2001; 342():10-20. PubMed ID: 11586885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
    Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
    EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methyladenosine-Substituted 2',5'-oligoadenylates: conformations, 2-5A binding and catalytic activities with human ribonuclease L.
    Kitade Y; Wakana M; Tsuboi T; Yatome C; Bayly SF; Player MR; Torrence PF
    Bioorg Med Chem Lett; 2000 Feb; 10(4):329-31. PubMed ID: 10714492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease.
    Floyd-Smith G; Slattery E; Lengyel P
    Science; 1981 May; 212(4498):1030-2. PubMed ID: 6165080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative function of a protein kinase homology domain in 2', 5'-oligoadenylate dependent RNase L.
    Dong B; Silverman RH
    Nucleic Acids Res; 1999 Jan; 27(2):439-45. PubMed ID: 9862963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 16. 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
    Salehzada T; Silhol M; Steff AM; Lebleu B; Bisbal C
    J Biol Chem; 1993 Apr; 268(11):7733-40. PubMed ID: 8463302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ribonuclease F by the two isomers (2'--5') oligoadenylate and (3'--5') oligoadenylate.
    Rappoport S; Arad G; Lapidot Y; Panet A
    FEBS Lett; 1982 Nov; 149(1):47-50. PubMed ID: 6759174
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of elevated 2',5'-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization.
    Yin H; Zhou A; Dai Y
    Lung Cancer; 2012 Oct; 78(1):30-8. PubMed ID: 22925698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-5A-dependent RNase molecules dimerize during activation by 2-5A.
    Dong B; Silverman RH
    J Biol Chem; 1995 Feb; 270(8):4133-7. PubMed ID: 7876164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.